RBOT Vicarious Surgical Inc.
Healthcare$0.99+4.64%ClosedMarket Cap: $6.4M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.86
P/S
0.00
EV/EBITDA
-0.29
DCF Value
$-1.02
FCF Yield
-617.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-333.2%
ROA
-334.6%
ROIC
-411.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-7.3M | $— |
| Q4 null | $0.00 | $-10.5M | $— |
| FY null | $0.00 | $-50.2M | $— |
| Q3 null | $0.00 | $-11.1M | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$8.75
Target (Median)
$8.75
Target Range
$7.00 - $10.50
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllSachs Adam Daviddirector, officer: President
SellTue Feb 24
Khalifa Sammydirector, officer: Chief Technology Officer
SellTue Feb 24
Sachs Adam Daviddirector, 10 percent owner, officer: President
SellThu Dec 04
Khalifa Sammydirector, 10 percent owner, officer: Chief Technology Officer
SellThu Dec 04
Sachs Adam Daviddirector, 10 percent owner, officer: President
SellFri Nov 21
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.50
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.